SpineEX Gains Patent for Expandable and Adjustable Lordosis Interbody Fusion System

SpineEX, Inc., a medical device company focused on the design, development and marketing of products for spine disorders, announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,188,527, which covers a novel mechanism that allows surgeons to adjust the posterior and anterior sides of an interbody fusion device independently of one another, giving surgeons more options for patient personalization. 
 
“As we prepare for the commencement of our commercial efforts later this month, it is critically important that we protect our intellectual property assets,” commented Roy Chin, Chairman and CEO. “The issuance of this patent by the USPTO further protects our innovative Sagittae product and we intend to further expand and strengthen our global IP, creating barriers to entry and and monetizing our R&D efforts.”
 
This latest patent expands the company’s intellectual property (IP) portfolio, which includes issued patents in the U.S. and China and several pending patent applications in other global jurisdictions. The company’s IP portfolio also includes the novel surgical instrumentation used to accompany the interbody fusion devices, along with other new expandable products utilizing aspects of the core platform technology.